Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
90 participants
INTERVENTIONAL
2016-04-30
2016-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
spray
apply the ethyl chloride spray before propofol injection
ethyl chloride spray
apply the spray for 5 seconds on the dorsal hand before propofol iv injection
lidocaine
apply the lidocaine 0.5 mg/kg under the touniquette state before propofol injection
lidocaine
apply lidocaine under the tourniquet state before propofol iv injection
placebo
apply the saline before propofol injection
placebo
apply normal saline before propofol iv injection
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ethyl chloride spray
apply the spray for 5 seconds on the dorsal hand before propofol iv injection
lidocaine
apply lidocaine under the tourniquet state before propofol iv injection
placebo
apply normal saline before propofol iv injection
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
20 Years
65 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Catholic University of Korea
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Young Eun Moon
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Youngeun Moon, MD
Role: PRINCIPAL_INVESTIGATOR
Assitant Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Youngeun Moon
Seoul, Seocho-gu, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CMC 2016-1
Identifier Type: -
Identifier Source: org_study_id